OSF HealthCare hospital transition to Epic on April 1 integrates patient data and expands digital tools at Saint Katharine Medical Center.

Portal Instruments, a medical device innovator focused on next-generation drug delivery platform, announced the signing of a multi-million-dollar development agreement with a leading biotech company ...

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension, today announced it has appointed Henry ...

NHS bosses say more staff are being recruited to work through up to 1,000 outstanding cases.

Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal hypertension ...

Patrick Soon-Shiong is pursuing a public offering for the media company, while juggling healthcare and tech pursuits.

Lebrikizumab delivered significant skin clearance and improved disease severity in children with moderate-to-severe atopic dermatitisADorable-1 met co-primary efficacy endpoints, with 63% of ...

Report reveals that FDA temperament and blockbuster drugs fall short of disrupting the ever-increasing orphan drug market LONDON – 13 March 2026 – Evaluate, the leading provider of market insights for ...